person · Reporting owner
Hussain Muhammad Raghib
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CIRRUS LOGIC, INC.CRUS · Entity 3854 | Director | July 29, 2026 | July 31, 2026 |
| Marvell Technology, Inc.MRVL · Entity 521 | President, Products & Tech | April 15, 2025 | April 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CIRRUS LOGIC, INC.
Report date July 29, 2026 · Filed July 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,579 |
Reported balance
After 2026-07-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-29 · Grant · Acquired 1,998 · Balance 10,579 F1: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 29, 2026. F2: Expiration Date of July 29, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-07-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-29 · Exercise / conversion · Disposed 1,998 · Balance 0 F1: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 29, 2026. F2: Expiration Date of July 29, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,623 |
Reported balance
After 2026-07-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-31 · Grant · Acquired 1,623 · Balance 1,623 F3: Each restricted stock unit represents a contingent right to receive one share of Cirrus Logic common stock. F4: Restricted Stock Units granted upon re-election to Cirrus Logic, Inc.'s Board of Directors. F5: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 31, 2027, the 1-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 29, 2026.
F2: Expiration Date of July 29, 2026.
F3: Each restricted stock unit represents a contingent right to receive one share of Cirrus Logic common stock.
F4: Restricted Stock Units granted upon re-election to Cirrus Logic, Inc.'s Board of Directors.
F5: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 31, 2027, the 1-year anniversary of the grant date.
Marvell Technology, Inc.
Report date April 15, 2025 · Filed April 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 722,889 |
Ending reported balance
After 2025-04-15 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2025-04-15 · Exercise / conversion · Acquired 3,171 · Balance 695,970 Row 2 · 2025-04-15 · Tax withholding · Disposed 1,573 · Balance 694,397 F1: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Row 3 · 2025-04-15 · Exercise / conversion · Acquired 5,315 · Balance 699,712 Row 4 · 2025-04-15 · Tax withholding · Disposed 2,636 · Balance 697,076 F1: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Row 5 · 2025-04-15 · Exercise / conversion · Acquired 3,252 · Balance 700,328 Row 6 · 2025-04-15 · Tax withholding · Disposed 1,613 · Balance 698,715 F1: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Row 7 · 2025-04-15 · Exercise / conversion · Acquired 47,946 · Balance 746,661 Row 8 · 2025-04-15 · Tax withholding · Disposed 23,772 · Balance 722,889 F1: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-04-15 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2025-04-15 · Exercise / conversion · Disposed 3,171 · Balance 0 F3: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F4: This award fully vested on April 15, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 21,259 |
Reported balance
After 2025-04-15 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2025-04-15 · Exercise / conversion · Disposed 5,315 · Balance 21,259 F3: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F5: The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 26,017 |
Reported balance
After 2025-04-15 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2025-04-15 · Exercise / conversion · Disposed 3,252 · Balance 26,017 F3: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F6: The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-04-15 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2025-04-15 · Exercise / conversion · Disposed 47,946 · Balance 0 F3: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F7: The grant is fully vested. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2022. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results that were certified on 04/15/2025. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trusts | 88,081 |
Reported balance
Holding disclosure · report date 2025-04-15 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 88,081 F2: Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs").
F2: Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family.
F3: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting.
F4: This award fully vested on April 15, 2025.
F5: The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026.
F6: The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027.
F7: The grant is fully vested. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2022. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results that were certified on 04/15/2025.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CAVIUM, INC.
Report date July 06, 2018 · Filed July 06, 2018
Section 16 reporting ended · disclosed 2018-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 135,222 |
Reported balance
After 2018-07-06 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2018-07-06 · Other · Disposed 228,698 · Balance 135,222 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. |
| Common StockSEC Table I · non-derivative | Direct | 15,543 |
Reported balance
After 2018-07-06 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2018-07-06 · Disposition to issuer · Disposed 83,679 · Balance 15,543 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F3: Represents shares of common stock of the Company underlying time-based restricted stock units ("RSUs"). F4: Disposed of pursuant to the Merger Agreement, whereby at the effective time of the Merger (the "Effective Time") each outstanding and unvested RSU was assumed and converted in the Merger into that number of Marvell restricted stock units of Marvell common stock, rounded down to the nearest whole share ("Converted RSUs"), equal to the product of (x) the number of shares of Company common stock subject to such RSU and (y) the Conversion Ratio (calculated to equal 4.0339). Any Converted RSU is subject to the same terms and conditions as were applicable under such RSU prior to the Effective Time. |
| Common StockSEC Table I · non-derivative | Direct | 9,364 |
Reported balance
After 2018-07-06 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2018-07-06 · Disposition to issuer · Disposed 6,179 · Balance 9,364 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F5: Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"). Until the Merger, the Reporting Person's right to this PRSU remained subject to the satisfaction of certain performance criteria. F6: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and unvested PRSU was assumed and converted in the Merger into that number of Marvell restricted stock units of Marvell common stock, rounded down to the nearest whole share ("Converted PRSUs"), equal to the product of (x) the number of shares of Company common stock subject to such PRSU, assuming achievement of target-level performance with respect to each performance period, performance cycle or measurement cycle applicable to such PRSU and (y) the Conversion Ratio (calculated to equal 4.0339). Any Converted PRSU shall (A) vest based on the vesting date set forth in the award agreement applicable to such PRSU prior to the Effective Time, subject only to the continued service of the grantee with the Company, Marvell or any of their affiliates through the applicable vesting date, (B) not be subject to any performance based vesting terms following the Effective Time and (continued in footnote 7) F7: (C) otherwise be subject to the same terms and conditions as were applicable under such PRSU prior to the Effective Time. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 5
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 5 · 2018-07-06 · Disposition to issuer · Disposed 9,364 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F5: Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"). Until the Merger, the Reporting Person's right to this PRSU remained subject to the satisfaction of certain performance criteria. F6: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and unvested PRSU was assumed and converted in the Merger into that number of Marvell restricted stock units of Marvell common stock, rounded down to the nearest whole share ("Converted PRSUs"), equal to the product of (x) the number of shares of Company common stock subject to such PRSU, assuming achievement of target-level performance with respect to each performance period, performance cycle or measurement cycle applicable to such PRSU and (y) the Conversion Ratio (calculated to equal 4.0339). Any Converted PRSU shall (A) vest based on the vesting date set forth in the award agreement applicable to such PRSU prior to the Effective Time, subject only to the continued service of the grantee with the Company, Marvell or any of their affiliates through the applicable vesting date, (B) not be subject to any performance based vesting terms following the Effective Time and (continued in footnote 7) F7: (C) otherwise be subject to the same terms and conditions as were applicable under such PRSU prior to the Effective Time. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 99,222 |
Reported balance
After 2018-07-06 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-07-06 · Disposition to issuer · Disposed 36,000 · Balance 99,222 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F2: Held in trusts of which the reporting person is the trustee, for the benefit of members of his immediate family. |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $37.63 · Expires 2020-03-22 | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-07-06 · Disposition to issuer · Disposed 10,000 · Balance 0 F8: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 9) F9: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $37.83 · Expires 2021-02-07 | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-07-06 · Disposition to issuer · Disposed 25,000 · Balance 0 F8: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 9) F9: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $62.86 · Expires 2022-02-16 | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-07-06 · Disposition to issuer · Disposed 12,886 · Balance 0 F8: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 9) F9: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $48.88 · Expires 2023-02-11 | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-07-06 · Disposition to issuer · Disposed 36,181 · Balance 0 F8: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 9) F9: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $65.80 · Expires 2024-02-10 | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-07-06 · Disposition to issuer · Disposed 28,762 · Balance 0 F8: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 9) F9: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018.
F2: Held in trusts of which the reporting person is the trustee, for the benefit of members of his immediate family.
F3: Represents shares of common stock of the Company underlying time-based restricted stock units ("RSUs").
F4: Disposed of pursuant to the Merger Agreement, whereby at the effective time of the Merger (the "Effective Time") each outstanding and unvested RSU was assumed and converted in the Merger into that number of Marvell restricted stock units of Marvell common stock, rounded down to the nearest whole share ("Converted RSUs"), equal to the product of (x) the number of shares of Company common stock subject to such RSU and (y) the Conversion Ratio (calculated to equal 4.0339). Any Converted RSU is subject to the same terms and conditions as were applicable under such RSU prior to the Effective Time.
F5: Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"). Until the Merger, the Reporting Person's right to this PRSU remained subject to the satisfaction of certain performance criteria.
F6: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and unvested PRSU was assumed and converted in the Merger into that number of Marvell restricted stock units of Marvell common stock, rounded down to the nearest whole share ("Converted PRSUs"), equal to the product of (x) the number of shares of Company common stock subject to such PRSU, assuming achievement of target-level performance with respect to each performance period, performance cycle or measurement cycle applicable to such PRSU and (y) the Conversion Ratio (calculated to equal 4.0339). Any Converted PRSU shall (A) vest based on the vesting date set forth in the award agreement applicable to such PRSU prior to the Effective Time, subject only to the continued service of the grantee with the Company, Marvell or any of their affiliates through the applicable vesting date, (B) not be subject to any performance based vesting terms following the Effective Time and (continued in footnote 7)
F7: (C) otherwise be subject to the same terms and conditions as were applicable under such PRSU prior to the Effective Time.
F8: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 9)
F9: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339).
MARVELL TECHNOLOGY GROUP LTD
Report date April 20, 2021 · Filed April 20, 2021
Section 16 reporting ended · disclosed 2021-04-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 1
1 source rowRow 1 · 2021-04-20 · Disposition to issuer · Disposed 759,059 · Balance 0 F1: On April 20, 2021, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 29, 2020 (the "Merger Agreement"), by and among Marvell Technology Group Ltd. ("Marvell"), Marvell Technology, Inc. (f/k/a Maui HoldCo, Inc.), a wholly owned subsidiary of Marvell ("HoldCo"), Maui Acquisition Company Ltd, a wholly owned subsidiary of HoldCo ("Bermuda Merger Sub"), Indigo Acquisition Corp., a wholly owned subsidiary of HoldCo ("Delaware Merger Sub"), and Inphi Corporation ("Inphi"), Bermuda Merger Sub merged with and into Marvell with Marvell as the surviving corporation and a wholly owned subsidiary of Holdco (the "Bermuda Merger"), and Delaware Merger Sub merged with and into Inphi with Inphi as the surviving corporation and a wholly owned subsidiary of Holdco (the "Delaware Merger" and, together with the Bermuda Merger, the "Mergers"). F2: (Continued from footnote 1) At the effective time of the Bermuda Merger, each common share of Marvell, par value $0.002 per share ("Marvell Share"), was automatically converted into the right to receive one share of HoldCo common stock, par value $0.002 per share ("HoldCo Stock"). |
| Common SharesSEC Table I · non-derivative | IndirectBy Family Trusts | 0 |
Reported balance
After 2021-04-20 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-04-20 · Disposition to issuer · Disposed 88,081 · Balance 0 F1: On April 20, 2021, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 29, 2020 (the "Merger Agreement"), by and among Marvell Technology Group Ltd. ("Marvell"), Marvell Technology, Inc. (f/k/a Maui HoldCo, Inc.), a wholly owned subsidiary of Marvell ("HoldCo"), Maui Acquisition Company Ltd, a wholly owned subsidiary of HoldCo ("Bermuda Merger Sub"), Indigo Acquisition Corp., a wholly owned subsidiary of HoldCo ("Delaware Merger Sub"), and Inphi Corporation ("Inphi"), Bermuda Merger Sub merged with and into Marvell with Marvell as the surviving corporation and a wholly owned subsidiary of Holdco (the "Bermuda Merger"), and Delaware Merger Sub merged with and into Inphi with Inphi as the surviving corporation and a wholly owned subsidiary of Holdco (the "Delaware Merger" and, together with the Bermuda Merger, the "Mergers"). F2: (Continued from footnote 1) At the effective time of the Bermuda Merger, each common share of Marvell, par value $0.002 per share ("Marvell Share"), was automatically converted into the right to receive one share of HoldCo common stock, par value $0.002 per share ("HoldCo Stock"). F3: Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-20 · Disposition to issuer · Disposed 35,540 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive one Marvell Share upon vesting. At the effective time of the Bermuda Merger, each restricted stock unit related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a restricted stock unit relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting) that applied to such restricted stock unit immediately prior to the Mergers, except that, for the performance-based restricted stock units, the performance measures will relate to HoldCo instead of Marvell. F5: The restricted stock units vest on August 15, 2021. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-20 · Disposition to issuer · Disposed 16,269 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive one Marvell Share upon vesting. At the effective time of the Bermuda Merger, each restricted stock unit related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a restricted stock unit relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting) that applied to such restricted stock unit immediately prior to the Mergers, except that, for the performance-based restricted stock units, the performance measures will relate to HoldCo instead of Marvell. F6: The restricted stock units vest on January 31, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-20 · Disposition to issuer · Disposed 27,415 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive one Marvell Share upon vesting. At the effective time of the Bermuda Merger, each restricted stock unit related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a restricted stock unit relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting) that applied to such restricted stock unit immediately prior to the Mergers, except that, for the performance-based restricted stock units, the performance measures will relate to HoldCo instead of Marvell. F7: The restricted stock units vest on each of 7/15/2021, 10/15/2021, 1/15/2022 and 4/15/2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-04-20 · Disposition to issuer · Disposed 55,667 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive one Marvell Share upon vesting. At the effective time of the Bermuda Merger, each restricted stock unit related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a restricted stock unit relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting) that applied to such restricted stock unit immediately prior to the Mergers, except that, for the performance-based restricted stock units, the performance measures will relate to HoldCo instead of Marvell. F8: The restricted stock units vest on each of 7/15/2021, 10/15/2021, 1/15/2022, 4/15/2022, 7/15/2022, 10/15/2022, 1/15/2023 and 4/15/2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-04-20 · Disposition to issuer · Disposed 39,668 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive one Marvell Share upon vesting. At the effective time of the Bermuda Merger, each restricted stock unit related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a restricted stock unit relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting) that applied to such restricted stock unit immediately prior to the Mergers, except that, for the performance-based restricted stock units, the performance measures will relate to HoldCo instead of Marvell. F9: The restricted stock units vest on each of 7/15/2021, 10/15/2021, 1/15/2022, 4/15/2022, 7/15/2022, 10/15/2022, 1/15/2023, 4/15/2023, 7/15/2023, 10/15/2023, 1/15/2024, and 4/15/2024. |
| Performance Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-04-20 · Disposition to issuer · Disposed 399,644 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive one Marvell Share upon vesting. At the effective time of the Bermuda Merger, each restricted stock unit related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a restricted stock unit relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting) that applied to such restricted stock unit immediately prior to the Mergers, except that, for the performance-based restricted stock units, the performance measures will relate to HoldCo instead of Marvell. F10: Value Creation Award that has been designed to provide a strong incentive to create a substantial increase in shareholder value. Vesting of these performance-based restricted stock units is dependent upon a significant increase in Marvell's stock price. The performance condition will be satisfied once Marvell's average stock price equals or exceeds $40.00 per share for 100 calendar days prior to the fourth anniversary of the date of grant ("Performance Condition"). The shares vest one year after the date the Performance Condition is satisfied. In the event of a change in control, the Performance Condition may be deemed partially satisfied depending on the value received in the transaction. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.33 · Expires 2020-03-22 | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-04-20 · Disposition to issuer · Disposed 40,339 · Balance 0 F11: Each stock option related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a stock option relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting and exercise price) that applied to stock option immediately prior to the Mergers. F12: Stock option was fully vested and exercisable prior to the Mergers. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.38 · Expires 2021-02-07 | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-04-20 · Disposition to issuer · Disposed 100,848 · Balance 0 F11: Each stock option related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a stock option relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting and exercise price) that applied to stock option immediately prior to the Mergers. F12: Stock option was fully vested and exercisable prior to the Mergers. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.58 · Expires 2022-02-16 | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-04-20 · Disposition to issuer · Disposed 51,981 · Balance 0 F11: Each stock option related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a stock option relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting and exercise price) that applied to stock option immediately prior to the Mergers. F12: Stock option was fully vested and exercisable prior to the Mergers. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.12 · Expires 2023-02-11 | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2021-04-20 · Disposition to issuer · Disposed 145,952 · Balance 0 F11: Each stock option related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a stock option relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting and exercise price) that applied to stock option immediately prior to the Mergers. F12: Stock option was fully vested and exercisable prior to the Mergers. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.31 · Expires 2024-02-10 | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2021-04-20 · Disposition to issuer · Disposed 116,024 · Balance 0 F11: Each stock option related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a stock option relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting and exercise price) that applied to stock option immediately prior to the Mergers. F12: Stock option was fully vested and exercisable prior to the Mergers. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 20, 2021, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 29, 2020 (the "Merger Agreement"), by and among Marvell Technology Group Ltd. ("Marvell"), Marvell Technology, Inc. (f/k/a Maui HoldCo, Inc.), a wholly owned subsidiary of Marvell ("HoldCo"), Maui Acquisition Company Ltd, a wholly owned subsidiary of HoldCo ("Bermuda Merger Sub"), Indigo Acquisition Corp., a wholly owned subsidiary of HoldCo ("Delaware Merger Sub"), and Inphi Corporation ("Inphi"), Bermuda Merger Sub merged with and into Marvell with Marvell as the surviving corporation and a wholly owned subsidiary of Holdco (the "Bermuda Merger"), and Delaware Merger Sub merged with and into Inphi with Inphi as the surviving corporation and a wholly owned subsidiary of Holdco (the "Delaware Merger" and, together with the Bermuda Merger, the "Mergers").
F2: (Continued from footnote 1) At the effective time of the Bermuda Merger, each common share of Marvell, par value $0.002 per share ("Marvell Share"), was automatically converted into the right to receive one share of HoldCo common stock, par value $0.002 per share ("HoldCo Stock").
F3: Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family.
F4: Each restricted stock unit represents a contingent right to receive one Marvell Share upon vesting. At the effective time of the Bermuda Merger, each restricted stock unit related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a restricted stock unit relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting) that applied to such restricted stock unit immediately prior to the Mergers, except that, for the performance-based restricted stock units, the performance measures will relate to HoldCo instead of Marvell.
F5: The restricted stock units vest on August 15, 2021.
F6: The restricted stock units vest on January 31, 2022.
F7: The restricted stock units vest on each of 7/15/2021, 10/15/2021, 1/15/2022 and 4/15/2022.
F8: The restricted stock units vest on each of 7/15/2021, 10/15/2021, 1/15/2022, 4/15/2022, 7/15/2022, 10/15/2022, 1/15/2023 and 4/15/2023.
F9: The restricted stock units vest on each of 7/15/2021, 10/15/2021, 1/15/2022, 4/15/2022, 7/15/2022, 10/15/2022, 1/15/2023, 4/15/2023, 7/15/2023, 10/15/2023, 1/15/2024, and 4/15/2024.
F10: Value Creation Award that has been designed to provide a strong incentive to create a substantial increase in shareholder value. Vesting of these performance-based restricted stock units is dependent upon a significant increase in Marvell's stock price. The performance condition will be satisfied once Marvell's average stock price equals or exceeds $40.00 per share for 100 calendar days prior to the fourth anniversary of the date of grant ("Performance Condition"). The shares vest one year after the date the Performance Condition is satisfied. In the event of a change in control, the Performance Condition may be deemed partially satisfied depending on the value received in the transaction.
F11: Each stock option related to a Marvell Share was assumed by HoldCo pursuant to the Merger Agreement and converted into a stock option relating to a share of HoldCo Stock, on the same terms and conditions as the original award (including with respect to vesting and exercise price) that applied to stock option immediately prior to the Mergers.
F12: Stock option was fully vested and exercisable prior to the Mergers.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Jul 31, 2026 21:01 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | GrantRestricted Stock Units · Derivative | 1,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001680691-26-000003 · wk-form4_1785531686.xml · derivative · entry 3 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,623 Underlying: Common Stock · 1,623 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cirrus Logic common stock. F4 · shares: Restricted Stock Units granted upon re-election to Cirrus Logic, Inc.'s Board of Directors. F5 · derivative.exercise_date: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 31, 2027, the 1-year anniversary of the grant date. F5 · derivative.expiration_date: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 31, 2027, the 1-year anniversary of the grant date. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:01 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | Exercise / conversionRestricted Stock Units · Derivative | 1,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001680691-26-000003 · wk-form4_1785531686.xml · derivative · entry 2 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,998 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 29, 2026. F2 · derivative.expiration_date: Expiration Date of July 29, 2026. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:01 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | GrantCommon Stock | 1,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001680691-26-000003 · wk-form4_1785531686.xml · nonDerivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,579 F1 · security: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 29, 2026. F2 · deemedExecutionDate: Expiration Date of July 29, 2026. Read SEC document |
| July 29, 2025 Filed Jul 29, 2025 22:46 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | GrantRestricted Stock Units · Derivative | 1,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001273902-25-000056 · wk-form4_1753829161.xml · derivative · entry 3 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,998 Underlying: Common Stock · 1,998 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cirrus Logic common stock. F4 · shares: Restricted Stock Units granted upon re-election to Cirrus Logic, Inc.'s Board of Directors. F5 · derivative.exercise_date: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 29,2026, the 1-year anniversary of the grant date. F5 · derivative.expiration_date: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 29,2026, the 1-year anniversary of the grant date. Read SEC document |
| July 26, 2025 Filed Jul 29, 2025 22:46 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | Exercise / conversionRestricted Stock Units · Derivative | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001273902-25-000056 · wk-form4_1753829161.xml · derivative · entry 2 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,624 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 26, 2025. F2 · derivative.expiration_date: Expiration Date of July 26, 2025. Read SEC document |
| July 26, 2025 Filed Jul 29, 2025 22:46 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | GrantCommon Stock | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001273902-25-000056 · wk-form4_1753829161.xml · nonDerivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,581 F1 · security: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 26, 2025. F2 · deemedExecutionDate: Expiration Date of July 26, 2025. Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 47,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · derivative · entry 13 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,946 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F7 · derivative.exercise_date: The grant is fully vested. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2022. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results that were certified on 04/15/2025. F7 · derivative.expiration_date: The grant is fully vested. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2022. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results that were certified on 04/15/2025. Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · derivative · entry 12 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,017 Underlying: Common Stock · 3,252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F6 · derivative.exercise_date: The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. F6 · derivative.expiration_date: The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 5,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · derivative · entry 11 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,259 Underlying: Common Stock · 5,315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F5 · derivative.exercise_date: The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026. F5 · derivative.expiration_date: The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026. Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 3,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · derivative · entry 10 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F4 · derivative.exercise_date: This award fully vested on April 15, 2025. F4 · derivative.expiration_date: This award fully vested on April 15, 2025. Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Stock | 23,772 | $53.32 | $1,267,523.04 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · nonDerivative · entry 8 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 722,889 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Stock | 47,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · nonDerivative · entry 7 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 746,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Stock | 1,613 | $53.32 | $86,005.16 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · nonDerivative · entry 6 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 698,715 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Stock | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · nonDerivative · entry 5 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Stock | 2,636 | $53.32 | $140,551.52 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · nonDerivative · entry 4 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 697,076 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Stock | 5,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · nonDerivative · entry 3 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 699,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Stock | 1,573 | $53.32 | $83,872.36 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · nonDerivative · entry 2 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 694,397 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 00:04 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Stock | 3,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000089 · wk-form4_1744934679.xml · nonDerivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 695,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:21 UTC | Marvell Technology, Inc. MRVL · Entity 521 | GrantRestricted Stock Units · Derivative | 74,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000041 · wk-form4_1738016502.xml · derivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,925 Underlying: Common Stock · 74,975 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F2 · derivative.exercise_date: This performance-based RSU included stock price and total stockholder return based performance vesting criteria. The performance condition for a tranche was certified on January 24, 2025. As a result of satisfaction of a stock price-based performance metric and the application of the second performance based criteria, a TSR modifier to the award, 74,975 shares are now solely subject to a service-based vesting condition pursuant to which 50% of the shares will be eligible to vest on the 3-year anniversary of the original grant date and 50% of the shares will be eligible to vest on the 5-year anniversary of the original grant date (subject to continued service to the company on the vesting dates). As of January 24, 2025 performance-based criteria have now been satisfied for 3 of the 4 performance-based tranches. F2 · derivative.expiration_date: This performance-based RSU included stock price and total stockholder return based performance vesting criteria. The performance condition for a tranche was certified on January 24, 2025. As a result of satisfaction of a stock price-based performance metric and the application of the second performance based criteria, a TSR modifier to the award, 74,975 shares are now solely subject to a service-based vesting condition pursuant to which 50% of the shares will be eligible to vest on the 3-year anniversary of the original grant date and 50% of the shares will be eligible to vest on the 5-year anniversary of the original grant date (subject to continued service to the company on the vesting dates). As of January 24, 2025 performance-based criteria have now been satisfied for 3 of the 4 performance-based tranches. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · derivative · entry 10 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,269 Underlying: Common Stock · 3,252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F6 · derivative.exercise_date: The remaining RSUs will vest on 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. F6 · derivative.expiration_date: The remaining RSUs will vest on 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 5,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · derivative · entry 9 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,574 Underlying: Common Stock · 5,315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F5 · derivative.exercise_date: The remaining RSUs will vest on 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, and 04/15/2026. F5 · derivative.expiration_date: The remaining RSUs will vest on 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, and 04/15/2026. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 3,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · derivative · entry 8 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,171 Underlying: Common Stock · 3,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F4 · derivative.exercise_date: The remaining RSUs will vest on 04/15/2025. F4 · derivative.expiration_date: The remaining RSUs will vest on 04/15/2025. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Shares | 1,613 | $116.00 | $187,108.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · nonDerivative · entry 6 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,799 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Shares | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · nonDerivative · entry 5 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 694,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Shares | 2,636 | $116.00 | $305,776.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · nonDerivative · entry 4 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 691,160 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Shares | 5,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · nonDerivative · entry 3 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 693,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Shares | 1,648 | $116.00 | $191,168.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · nonDerivative · entry 2 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 688,481 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:03 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Shares | 3,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-25-000018 · wk-form4_1737165789.xml · nonDerivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 690,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 24, 2024 Filed Dec 26, 2024 18:26 UTC | Marvell Technology, Inc. MRVL · Entity 521 | GiftCommon Shares | 13,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000221 · wk-form4_1735237567.xml · nonDerivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686,958 F1 · shares: The reported disposition represents a bona fide charitable gift made by the Reporting Person. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 19:33 UTC | Marvell Technology, Inc. MRVL · Entity 521 | GrantRestricted Stock Units · Derivative | 74,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000204 · wk-form4_1733772816.xml · derivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,950 Underlying: Common Stock · 74,975 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F2 · derivative.exercise_date: This performance-based RSU included stock price and total stockholder return based performance vesting criteria. The performance condition for a tranche was certified on December 5, 2024. As a result of satisfaction of a stock price-based performance metric and the application of the second performance based criteria, a TSR modifier to the award, 74,975 shares are now solely subject to a service-based vesting condition pursuant to which 50% of the shares will be eligible to vest on the 3-year anniversary of the original grant date and 50% of the shares will be eligible to vest on the 5-year anniversary of the original grant date (subject to continued service to the company on the vesting dates). As of December 5, 2024 performance-based criteria have now been satisfied for 2 of the 4 performance-based tranches. F2 · derivative.expiration_date: This performance-based RSU included stock price and total stockholder return based performance vesting criteria. The performance condition for a tranche was certified on December 5, 2024. As a result of satisfaction of a stock price-based performance metric and the application of the second performance based criteria, a TSR modifier to the award, 74,975 shares are now solely subject to a service-based vesting condition pursuant to which 50% of the shares will be eligible to vest on the 3-year anniversary of the original grant date and 50% of the shares will be eligible to vest on the 5-year anniversary of the original grant date (subject to continued service to the company on the vesting dates). As of December 5, 2024 performance-based criteria have now been satisfied for 2 of the 4 performance-based tranches. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · derivative · entry 11 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,521 Underlying: Common Stock · 3,252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F7 · derivative.exercise_date: The remaining RSUs will vest on 01/15/2025, 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. F7 · derivative.expiration_date: The remaining RSUs will vest on 01/15/2025, 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 5,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · derivative · entry 10 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,889 Underlying: Common Stock · 5,315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F6 · derivative.exercise_date: The remaining RSUs will vest on 01/15/2025, 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, and 04/15/2026. F6 · derivative.expiration_date: The remaining RSUs will vest on 01/15/2025, 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, and 04/15/2026. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 3,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · derivative · entry 9 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,342 Underlying: Common Stock · 3,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F5 · derivative.exercise_date: The remaining RSUs will vest on 01/15/2025 and 04/15/2025. F5 · derivative.expiration_date: The remaining RSUs will vest on 01/15/2025 and 04/15/2025. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Shares | 1,613 | $79.41 | $128,088.33 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · nonDerivative · entry 7 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 700,403 F2 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Shares | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · nonDerivative · entry 6 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 702,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Shares | 2,636 | $79.41 | $209,324.76 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · nonDerivative · entry 5 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 698,764 F2 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Shares | 5,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · nonDerivative · entry 4 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 701,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Shares | 1,573 | $79.41 | $124,911.93 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · nonDerivative · entry 3 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 696,085 F2 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Shares | 3,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · nonDerivative · entry 2 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 697,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:56 UTC | Marvell Technology, Inc. MRVL · Entity 521 | SaleCommon Shares | 150,000 | $80.50 | $12,075,000.00 |
DisclosureSEC source: 0001835632-24-000181 · wk-form4_1729205807.xml · nonDerivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 694,487 F1 · kind: Sales were made pursuant to a 10b5-1 Plan dated March 27, 2024. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 20:27 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | GrantRestricted Stock Units · Derivative | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001273902-24-000066 · wk-form4_1722371217.xml · derivative · entry 3 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,248 Underlying: Common Stock · 1,624 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cirrus Logic common stock. F4 · shares: Restricted Stock Units granted upon re-election to Cirrus Logic, Inc.'s Board of Directors. F5 · derivative.exercise_date: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 26, 2025, the 1-year anniversary of the grant date. F5 · derivative.expiration_date: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 26, 2025, the 1-year anniversary of the grant date. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 20:27 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | Exercise / conversionRestricted Stock Units · Derivative | 2,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001273902-24-000066 · wk-form4_1722371217.xml · derivative · entry 2 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 26, 2024. F2 · derivative.expiration_date: Expiration Date of July 26, 2024. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 20:27 UTC | CIRRUS LOGIC, INC. CRUS · Entity 3854 | GrantCommon Stock | 2,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001273902-24-000066 · wk-form4_1722371217.xml · nonDerivative · entry 1 Hussain Muhammad Raghib · CIK 0001680691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,957 F1 · security: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock units vested on July 26, 2024. F2 · deemedExecutionDate: Expiration Date of July 26, 2024. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:13 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000119 · wk-form4_1721164433.xml · derivative · entry 10 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,773 Underlying: Common Stock · 3,252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F6 · derivative.exercise_date: The remaining RSUs will vest on 10/15/2024, 01/15/2025, 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. F6 · derivative.expiration_date: The remaining RSUs will vest on 10/15/2024, 01/15/2025, 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:13 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 5,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000119 · wk-form4_1721164433.xml · derivative · entry 9 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,204 Underlying: Common Stock · 5,314 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F5 · derivative.exercise_date: The remaining RSUs will vest on 10/15/2024, 01/15/2025, 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026. F5 · derivative.expiration_date: The remaining RSUs will vest on 10/15/2024, 01/15/2025, 04/15/2025, 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:13 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionRestricted Stock Units · Derivative | 3,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000119 · wk-form4_1721164433.xml · derivative · entry 8 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,513 Underlying: Common Stock · 3,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. F4 · derivative.exercise_date: The remaining RSUs will vest on 10/15/2024, 01/15/2025 and 04/15/2025. F4 · derivative.expiration_date: The remaining RSUs will vest on 10/15/2024, 01/15/2025 and 04/15/2025. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:13 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Stock | 1,613 | $73.60 | $118,716.80 |
DisclosureSEC source: 0001835632-24-000119 · wk-form4_1721164433.xml · nonDerivative · entry 6 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 844,487 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:13 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Stock | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000119 · wk-form4_1721164433.xml · nonDerivative · entry 5 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 846,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:13 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Tax withholdingCommon Stock | 2,635 | $73.60 | $193,936.00 |
DisclosureSEC source: 0001835632-24-000119 · wk-form4_1721164433.xml · nonDerivative · entry 4 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 842,848 F1 · kind: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:13 UTC | Marvell Technology, Inc. MRVL · Entity 521 | Exercise / conversionCommon Stock | 5,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001835632-24-000119 · wk-form4_1721164433.xml · nonDerivative · entry 3 Hussain Muhammad Raghib · CIK 0001680691 · President, Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 845,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.